Chromatin regulation controls access to genes (IMAGE)
Caption
Emily Dykhuizen is an expert in chromatin regulation, exploring the cellular machinery that controls access to genes and developing molecules that selectively inhibit access as the basis of new cancer therapies. Her research findings include discovering a previously unknown regulator that plays a role in prostate cancer, designing an inhibitor that could wipe out HIV and one that helps researchers understand therapy resistance. Her lab is currently testing inhibitors they designed to control metastasis in breast cancer. Her background in organic chemistry is a unique advantage in a complicated biological field, as she brings a deep understanding of chemical interactions to her work designing effective molecular inhibitors.
Credit
Purdue University photo/Kelsey Lefever
Usage Restrictions
none
License
Licensed content